Thromboxane and histamine mediate PVR elevation during xenogeneic pig lung perfusion with human blood

Elevated pulmonary vascular resistance (PVR), platelet adhesion, coagulation activation, and inflammation are prominent features of xenolung rejection. Here, we evaluate the role of thromboxane and histamine on PVR, and their contribution to other lung xenograft injury mechanisms.

[1]  R. Pierson,et al.  Platelet sequestration and activation during GalTKO.hCD46 pig lung perfusion by human blood is primarily mediated by GPIb, GPIIb/IIIa, and von Willebrand Factor , 2016, Xenotransplantation.

[2]  R. Pierson,et al.  Meta‐analysis of the independent and cumulative effects of multiple genetic modifications on pig lung xenograft performance during ex vivo perfusion with human blood , 2015, Xenotransplantation.

[3]  R. Pierson,et al.  Systemic inflammation in xenograft recipients precedes activation of coagulation , 2015, Xenotransplantation.

[4]  R. Pierson,et al.  Lung xenotransplantation: recent progress and current status , 2014, Xenotransplantation.

[5]  Marvin L. Thomas,et al.  Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation. , 2014, The Journal of thoracic and cardiovascular surgery.

[6]  D. Cooper,et al.  Progress in pig‐to‐non‐human primate transplantation models (1998–2013): a comprehensive review of the literature , 2014, Xenotransplantation.

[7]  R. Pierson,et al.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation , 2014, Xenotransplantation.

[8]  I. Wamala,et al.  Increased transfusion‐free survival following auxiliary pig liver xenotransplantation , 2014, Xenotransplantation.

[9]  S. Matsumoto,et al.  Clinical porcine islet xenotransplantation under comprehensive regulation. , 2014, Transplantation proceedings.

[10]  A. Kirk,et al.  Islet cell xenotransplantation: a serious look toward the clinic , 2014, Xenotransplantation.

[11]  D. Ayares,et al.  Expression of Human CD46 Modulates Inflammation Associated With GalTKO Lung Xenograft Injury , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  B. Østerud,et al.  Pro- and anti-inflammatory effects of histamine on tissue factor and TNFα expression in monocytes of human blood. , 2014, Thrombosis research.

[13]  H. Hara,et al.  Corneal blindness and xenotransplantation , 2014, Xenotransplantation.

[14]  R. Pierson,et al.  Activated Protein C Decreases Thrombosis onPorcine Endothelium Transgenic for Human Endothelial Protein C Receptor - A Novel Mechanism to Decrease Porcine Xenograft Injury. , 2014 .

[15]  R. F. Hoyt,et al.  One‐Year Heterotopic Cardiac Xenograft Survival in a Pig to Baboon Model , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  D. Cooper,et al.  KIDNEY XENOTRANSPLANTATION , 2013, Kidney international.

[17]  D. Cooper,et al.  Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition , 2014, Xenotransplantation.

[18]  T. Kawamura,et al.  The suppression of inflammatory macrophage-mediated cytotoxicity and proinflammatory cytokine production by transgenic expression of HLA-E. , 2013, Transplant immunology.

[19]  G. Snell,et al.  Sustained function of genetically modified porcine lungs in an ex vivo model of pulmonary xenotransplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  Yifan Dai,et al.  The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation , 2013, Journal of biomedical research.

[21]  I. Wamala,et al.  Up to 9‐day survival and control of thrombocytopenia following alpha1,3‐galactosyl transferase knockout swine liver xenotransplantation in baboons , 2012, Xenotransplantation.

[22]  H. Tazelaar,et al.  Human CD55 Expression Blocks Hyperacute Rejection and Restricts Complement Activation in Gal Knockout Cardiac Xenografts , 2012, Transplantation.

[23]  C. McGregor,et al.  Cardiac xenotransplantation: progress and challenges , 2012, Current opinion in organ transplantation.

[24]  R. Pierson,et al.  Xenogeneic lung transplantation models. , 2012, Methods in molecular biology.

[25]  D. Sachs,et al.  Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection , 2011, Xenotransplantation.

[26]  D. Cooper,et al.  Recipient Tissue Factor Expression Is Associated With Consumptive Coagulopathy in Pig‐to‐Primate Kidney Xenotransplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  M. Irikura,et al.  A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs. , 2009, Journal of pharmacological sciences.

[28]  B. Hering,et al.  Pig-to-nonhuman primate islet xenotransplantation. , 2009, Transplant immunology.

[29]  D. Sachs,et al.  Rejection of Cardiac Xenografts Transplanted from α1,3‐Galactosyltransferase Gene‐Knockout (GalT‐KO) Pigs to Baboons , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  J. Catravas,et al.  Endothelial pathomechanisms in acute lung injury , 2008, Vascular Pharmacology.

[31]  D. Cooper,et al.  Recent advances in pig-to-human organ and cell transplantation , 2008, Expert opinion on biological therapy.

[32]  Mi Jung Kim,et al.  The Role of Endogenous Histamine on the Pathogenesis of the Lipopolysaccharide (LPS)-Induced, Acute Lung Injury: A Pilot Study , 2006, Inflammation.

[33]  S. Bhattacharya,et al.  Anti-inflammatory effect of intraventricularly administered histamine in rats , 1985, Agents and Actions.

[34]  R. Pierson,et al.  Hyperacute rejection is attenuated in GalT knockout swine lungs perfused ex vivo with human blood. , 2005, Transplantation proceedings.

[35]  R. Pierson,et al.  Hyperacute lung rejection in the pig‐to‐human model. 2. Synergy between soluble and membrane complement inhibition , 2003, Xenotransplantation.

[36]  K. Kubo,et al.  Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity. , 2001, The Journal of laboratory and clinical medicine.

[37]  R. Pierson,et al.  Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection. , 2001, Journal of applied physiology.

[38]  Pierson Rn rd,et al.  Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood. , 1996 .

[39]  R. Pierson,et al.  Thromboxane mediates pulmonary vasoconstriction and contributes to cytotoxicity in pig lungs perfused with fresh human blood. , 1996, Transplantation Proceedings.

[40]  P. Howard,et al.  Histamine induced pulmonary vasodilatation in the rat: site of action and changes in chronic hypoxia. , 1994, The European respiratory journal.

[41]  P. Barnes,et al.  Histamine receptors in the lung. , 1991, Agents and actions. Supplements.

[42]  C. Blocher,et al.  Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model. , 1987, Surgery.

[43]  D. Henry,et al.  Role of histamine in acute oleic acid-induced lung injury. , 1986, Journal of applied physiology.

[44]  L. Lichtenstein,et al.  Human lung macrophages induce histamine release from basophils and mast cells. , 1985, The American review of respiratory disease.

[45]  P. Barnes,et al.  HISTAMINE INCREASES LUNG PERMEABILITY BY AN H2-RECEPTOR MECHANISM , 1984, The Lancet.

[46]  B. Meyrick,et al.  Increased permeability associated with dilatation of endothelial cell junctions caused by histamine in intimal explants from bovine pulmonary artery. , 1984, Experimental lung research.

[47]  J. Snapper,et al.  Prostaglandins and lung injury. , 1983, Chest.

[48]  K. Tanaka,et al.  Protective effect of a thromboxane synthetase inhibitor, OKY-1581, on increased lung vascular permeability in pulmonary microembolization in dogs. , 1983, Prostaglandins, leukotrienes, and medicine.

[49]  C. Emery,et al.  H1 and H2 histamine actions on lung vessels; their relevance to hypoxic vasoconstriction. , 1978, Quarterly journal of experimental physiology and cognate medical sciences.